Cosmetic vs Reconstructive Revenue: How Lenders Underwrite
When a lender reviews a plastic surgery practice, one of the first questions is where the money comes from. Cosmetic vs reconstructive revenue can look very different on paper: cosmetic procedures are usually paid directly by patients and driven by marketing, while reconstructive work is often billed to insurers and tied to referrals and hospital relationships. Each carries its own strengths and risks, and the mix can influence how a loan is sized and structured.
This article explains how lenders may view each revenue stream and how practices can present their revenue mix more clearly. Underwriting standards vary by lender and program, and nothing here is legal, billing, coding or compliance advice.
How Cosmetic Revenue Is Typically Viewed
Cosmetic revenue has some features lenders tend to like:
- Patients often pay in advance, so there may be little in accounts receivable
- Pricing is set by the practice rather than by a payer fee schedule
- There is no claim denial or payer audit risk on cash-pay services
It also has features lenders examine closely:
- Cyclicality: elective procedures may decline when consumer confidence weakens
- Marketing dependence: new patient volume may rely on ongoing advertising spend
- Surgeon dependence: patients often choose the individual surgeon, which raises transition risk in an acquisition
- Seasonality: some procedures cluster around certain times of year
- Prepaid obligations: deposits and packages represent services still owed to patients
How Reconstructive Revenue Is Typically Viewed
Reconstructive work, such as procedures following cancer treatment, trauma or congenital conditions, is often covered by commercial insurers, Medicare or Medicaid. Lenders may see some stability in this income because demand is less tied to discretionary spending.
At the same time, reconstructive revenue brings its own considerations:
- Reimbursement is set by payers and can change over time
- Claims take time to collect, creating accounts receivable
- Prior authorization and documentation requirements may delay payment
- Volume may depend on referral relationships and hospital privileges
- Payer contracts, credentialing and enrollments should not be assumed to transfer in a sale
Billing and documentation practices should be reviewed by qualified billing or compliance professionals, particularly in an acquisition.
Why the Mix of Cosmetic vs Reconstructive Revenue Matters
Many lenders view a balanced practice as having some natural diversification. When elective demand softens, insurance-based work may help support cash flow. When reimbursement pressure rises, cash-pay revenue may help offset it.
A heavily cosmetic practice is not necessarily a weaker borrower, and a heavily reconstructive practice is not necessarily a stronger one. What matters most is the consistency of cash flow over time, how the practice performed in softer periods and how well the revenue is documented.
How the Revenue Mix Can Shape Loan Structure
Depending on the lender and the deal, the revenue profile may influence:
- Loan sizing: lenders may give more weight to earnings they believe will continue after a sale or downturn
- Equity and reserves: a lender may ask for more equity or require post-closing liquidity if revenue is volatile
- Working capital: reconstructive practices with significant receivables, or cosmetic practices with seasonal swings, may need a line of credit alongside a term loan
- Seller involvement: in acquisitions, a longer seller transition or a seller note may be requested when revenue is tied to the selling surgeon
Seller notes are typically subordinate to the senior loan, and lenders or programs may limit earnouts. Every loan is subject to approval.
SBA and Conventional Perspectives
SBA 7(a) loans may be used for acquisitions and working capital in both cosmetic and reconstructive practices, subject to eligibility, program rules and lender review. Conventional lenders apply their own standards and may weigh revenue concentration differently. Our overview of plastic surgery practice loans compares the main options.
Questions Lenders May Ask
Expect a lender to probe the story behind the numbers. Common questions include:
- How did revenue hold up during past slowdowns in elective demand?
- Which marketing channels produce most new consultations, and what do they cost?
- How many reconstructive referrals come from a small number of sources?
- Have there been any recent payer audits or significant claim denials?
- How would revenue change if one surgeon reduced hours or left?
Thoughtful, documented answers can help a lender understand the practice and may support a more suitable structure.
How to Present Your Revenue to a Lender
Clear reporting can make a meaningful difference in how cosmetic vs reconstructive revenue is evaluated. Consider preparing:
- Revenue by category: surgical cosmetic, nonsurgical cosmetic and reconstructive
- Revenue by surgeon and provider
- Monthly revenue over several years to show seasonality and trends
- Accounts receivable aging for insurance-based work
- A schedule of patient deposits and prepaid packages
- Marketing spend and new consultation trends
This information also helps buyers and appraisers, as explained in our article on plastic surgery practice valuation.
Managing Cash Flow Across Both Revenue Streams
Cosmetic practices may need to fund marketing ahead of surgical demand, while reconstructive practices may wait on insurance payments. A plastic surgery line of credit or other working capital solutions can help smooth these timing differences when used for short-term needs rather than long-term investments.
Final Thoughts
Neither revenue stream is inherently better in a lender’s eyes. Understanding how lenders weigh cyclicality, marketing dependence, reimbursement and receivables can help plastic surgeons present their practices clearly and pursue a loan structure that fits how the practice actually earns its income.
US Medical Funding helps plastic surgeons finance acquisitions, buy-ins and growth with structures that reflect their revenue mix. Learn more about our plastic surgery practice acquisition financing and our full range of plastic surgery practice financing options.
